Clinical Importance of Adherence to Treatment With Eicosapentaenoic Acid by Patients With Hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Importance of Adherence to Treatment With Eicosapentaenoic Acid by Patients With Hypercholesterolemia

Published:2010 Issue:3 Volume:74 Page:510-517
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Origasa Hideki¹,Yokoyama Mitsuhiro²,Matsuzaki Masunori³,Saito Yasushi⁴,Matsuzawa Yuji⁵,The JELIS Investigators

Affiliation:

1. Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine

2. Hyogo Prefectural Awaji Hospital

3. Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

4. Chiba University

5. Sumitomo Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/74/3/74_CJ-09-0746/_pdf

Reference37 articles.

1. 1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.

2. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

3. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

4. 4. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Arch Intern Med 2007; 167: 1798-1803.

5. 5. Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, Birt J, et al. Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 1998; 7: 168-174.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial;Journal of Atherosclerosis and Thrombosis;2023-11-01

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

3. Marine-derived n-3 fatty acids therapy for stroke;Cochrane Database of Systematic Reviews;2022-06-29

4. Digital Technology Tools to Examine Patient Adherence to a Prescription-Only Omega-3 Polyunsaturated Fatty Acid Therapy To Mitigate Cardiovascular Risk: Protocol for a Prospective Observational Study and Preliminary Demographic Analysis;JMIR Research Protocols;2021-08-30

5. Statin Intolerance Clinical Guide 2018;Journal of Atherosclerosis and Thrombosis;2020-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3